论文部分内容阅读
宫颈癌是发生在全球妇女仅次于乳腺癌第二个最常见的肿瘤。宫颈癌的发生同其它肿瘤一样也是多步骤、多基因的结果。随着其发病的普遍性,关于它的相关研究近年来日益受到重视且也取得了可喜的进展,但仍有许多患者治疗效果不理想、复发率高,术后5年生存率低下。这其中就有许多复杂的因素与宫颈癌的生物学行为有关并影响患者的预后。本文从宫颈癌的病因、病理参数、分子生物学指标等方面就宫颈癌的预后的研究做一简要综述。
Cervical cancer is the second most common cancer in women worldwide after breast cancer. Cervical cancer, like other tumors, is also a multi-step, multi-gene result. With its prevalence, its related research has been paid more and more attention in recent years, and also made gratifying progress, but there are still many patients with unsatisfactory treatment effect, high recurrence rate, and low postoperative 5-year survival rate. There are many complex factors which are related to the biological behavior of cervical cancer and affect the prognosis of patients. This article from the etiology of cervical cancer, pathological parameters, molecular biology and other aspects of the prognosis of cervical cancer to do a brief review.